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We have used the polymerase chain reaction (PCR) to study deletions in the mitochondrial DNA (mtDNA) of an elderly human individual, An 
extended set of PCR primers has been utilised to identify 10 m tochondrial DNA deletions in a 69-year-old female subject with no known 
mitochondrial disease. The particular deletions visualised as PCR products depended on the primer pairs u ed, such that the more distantly 
separated PCR primers enabled visualisation of larger deletions. Some deletions were common to the heart, brain and skeletal muscle, whereas 
others were apparently specific to individual tissues. DNA sequencing analysis of PCR products howed that short direct repeat sequences (5 to 
13 bp) flanked all deletion breakpoints; in most casesone copy of the repeat was deleted, It is proposed that the accumulation f such multiple 
deletions is a general phenomenon during the ageing process. 
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I. INTRODUCTION 
It has been proposed that the accumulation of somat- 
ic gene mutations in the mitochondrial DNA (mtDNA) 
during life is an important contributor to ageing and 
diseases [1]. In support of this hypothesis, our labo- 
ratory [2] and others [3,4] have utilised the polymerase 
chain reaction (FCR) to demonstrate the age-related 
occurrence of a particular 4977 bp deletion in mtDNA 
of various human tissues including skeletal muscle, 
heart, brain and several internal organs. This same dele- 
tion had been previously shown to be present in tissues 
of patients with mitochondrial diseases [5-7]. Other 
deletions affecting mtDNA have been reported in 
patients, suffering from mitoehondrial myopathy [8-11] 
and cardiomyopathy [12]. Among these reported 
mtDNA deletions, a 7436 bp deletion, which was orig. 
inall2¢ detected in the cardiomyocytes of cardio- 
myopathy patients [12], was subsequently shown to 
occur in an age-related manner in the cardiomyocytes 
of subjects without manifest cardiac disease [13]. 
Such deletions in mtDNA generally occur in the 
longer region between the physically separated origins 
of replication of the heavy and light DNA strands. Singe 
the heavy strand is exposed as a single strand for a 
considerable time during replication and most of the 
deletions have short direct repeat sequences in the vi- 
cinity of the breakpoint, a slipped mispairing mccha- 
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nism has been suggested to generate deletions [6]. An 
examination of the human mitochondrial genome indi- 
cates that there are numerous direct repeats of 4 bp or 
more. Since direct repeats as short as 4 bp have been 
shown to be involved in mtDNA deletion in mito- 
chondrial myopathies [8,9], we predict that a wide 
spectrum of further mtDNA deletions hould be found 
in humans as part of the ageing process. Yet it is a 
common experience that use of one given pair of PCR 
primers picks up only one predominant deletion 
[2,3,14]. 
We therefore have undertaken a systematic study of 
primers in ,carious combinations to see if further dele- 
tions of human mtDNA could be observed. We report 
here that in fact there are multiple mtDNA deletions 
evident in an aged human subject. Our results indicate 
that any particular deletion could be detected with only 
a subset of primer pairs. While some deletions were 
common in the three tissues tested (heart~ brain and 
skeletal muscle), other deletions were accumulated in
skeletal muscle only. 
2. MATERIALS AND METHODS 
2,1. Source of tissues 
Heart, brain and skdt'tal muscle were taken at autopsy from a 
69-year-old female who had died of primary carcinoma of splenic 
flexure of bowel. She had nosymptoms of mitochondrial myopathies 
upon death, 
2.2. Preparation of DNA 
Total cellular DNA was isolated from lif0 mg tissue samples by the 
rapid DNA preparation procedure described y Davis ot al. [15], wlth 
the following modifications, Proteinasc K (Boehringer Mannheim) 
was ineluded in the SDS extraction step at a final concentration f 200 
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,f@nl followed by extended overnight incubation at 37°C. The subse- 
quent polassium acetate precipitation of SDS was also omitted, 
2.3. Polytnsruss chin reamott (PCR) 
PCR was carried out in an lnnovonics Gcnc Machine, in which 
reaction tubes arc automatically transferred between three water/oil 
baths, Total cellular DNA (I fly) was amplified in 100 (ul reaction 
mixture containing 200 PM of each dNTP, 40 pmol of each primer, 
2.5 U of Taq DNA polymcrasc (Pcrkin~Elmcr/Cctus). 50 mM KCI. 
IO mM Tris-WI (pH 8.3) 1.5 mM MgC&, 0.01% (w/v) gelatin (Sigma- 
Porcine Skin type I) and 0.1% Triton X-100 (BDH). The mixture was 
overlaid with IOOyl paraffin oil (Fluka) und the reaction carried out 
for 30 cycles under the following conditions: dcnaturation, 60 s at 
94°C; annealing, 90 s at WC; primer extension, I50 s at 72°C (in the 
initial cycle, the dcnaturation step was extended to 300 s). The 
amplified products were separated electrophoretically on a 1% agarose 
gel and the DNA detected after staining with cthidium bromide and 
irradiating under ultraviolet light. 
2.4. Ofigotttrcfrwridc prittws 
Oligonuclcotide primers were synthesized using an Applied Bio- 
systems model 380A DNA synthesircr and purified using Applied 
Biosystems OPC cdrlridges. Their sequence and corresponding posi- 
tion on the human mlDNA genomc are described in Table I. 
2.5. DNA clotting ottd scqtt~ttcittg 
The PCR product was treated with Klenow fragment as described 
by Obcmmaicr-Kusscr ct al. [7] to eliminate artcfactually polymerised 
dcoxyadcnylic ucid ut the 3’ end. The desired product bearing a dcle- 
tion was purified with the Geneclean Kit (Bio 101 Inc.) after agarosc 
gel electrophorcsis and cloned by blunt-end ligation into pUCl3 cut 
with Sttrrtl. Double strund sequencing of the mtDNA fragments was 
pcrrormcd using a Pham?acia T7 Sequencing Kit according to the 
manufacturer’s instructions, The prhncrs used for DNA sequencing 
were the universal sequencing primer, L7901 or L8316. 
3. R&LILTS 
The primers L7901 and H 13631 have been routinely 
used in PCR analysis for the detection of the 4977 bp 
deletion [2,4,14]. The full size segment amplified with 
this pair of primers is 5.75 kb. An additional 0.77 kb 
product was consistently amplified from DNA of adult 
tissues, indicating the presence of mtDNA templates 
bearing the 4977 bp deletion [2]. This primer pair was 
used here for PCR amplification from DNA extracted 
from the heart, brain and skeletal muscle of a 6%year- 
old female. The 0.77 kb fragment was amplified from 
each tissue (Fig. I, lanes b, c and d). In subsequent PCR 
analyses, L79Ol was paired with three more primers, 
each shifted a different distance further away from 
H13631 (Table II). In general, the products amplified 
did not always correspond to the expected size after the 
4977 bp deletion (data in Fig. 1 and summarized in 
Table 11). Furthermore, multiple bands were observed 
in some samples. 
Primers pairs L7901 -I- H 13905, which shifted 278 bp 
from L7901 + HI 363 I, gave the expected 1.05 kb prod- 
uct corresponding to the 4977 bp deletion in all three 
tissues tested (Fig. 1 9 lanes e, f and g). In addition, a 0.20 
kb molecule was amplified in the skeletal muscle (but 
not heart and brain) suggesting a larger deletion of 
about 5.83 kb (Fig. 1, lane g). L7901 was combined with 
H 14850 which shifted 1223 bp from H 13631. The 1996 
bp expected product predicted for the 4977 bp deletion 
was not seen (Fig. 1, lanes h, i and j); instead, a Ct.64 kb 
molecule was amplified in the skeletal muscle, predict- 
ing a 6.33 kb deletion (Fig. 1, lane j). When L7901 + 
H 165 14 were used as the primers, which shifted 2890 bp 
from L790 I + H1363 1, there was no product of 3663 bp 
corresponding to the 4977 bp deletion (Fig. 1, lanes k, 
I and m). In its place, two products of 1.20 and 060 kb 
were amplified from all tissues (Fig. I, lanes k, I and m), 
suggesting the presence of two deletions of 7.44 and 8.04 
kb respectively. Moreover, three additional products of 
1.01, 0.90 and 0.73 kb, indicative of further deletions, 
were amplified from the skeletal muscle (Fig. 1, lane rn). 
H13631 was then combined with L7293 which shifted 
608 bp from L7901 towards the other direction. The 
1.38 kb product expected for the 4977 bp deletion was 
amplified from all tissues (Fig. 1, lanes n, o and p), and 
an additional 0.60 kb molecule was also amplified from 
the skeletal muscle (Fig. I, lane p), corresponding to a 
deletion of about 5.76 kb. 
Initially, products of the same size amplified from 
different issues with the same primer combination were 
assumed to be the same and were given a single deletion 
code number (Table II). One fragment of each size was 
cloned into pUCl3 and the deletion breakpoint se- 
quenced. Nine deletions were found to be represented 
amongst he 11 fragments amplified (Table III). Dele- 
tions 1, 2 and IO represent the same 4977 bp deletion. 
In most other cases here, direct repeat sequences (5 to 
12 bp) were found atthe boundaries of the deletions and 
one copy of the repeat was deleted. An exception is 
deletion 8 which retained both repeats. However, when 
DNA bearing deletion 9 amplified from the skeletal 
muscle was sequenced (deletion 9-2 of Table III), it was 
Primer 
Table I 
Oligonuclcotide primers for PCR 
SW ucnce s-3 Nuclcotidc position 
L7293 GCAGTAATATTAA- 7293 to 7316 
L790 I
La316 
HI3631 
H 13905 
H14ft50 
TAATTTTCATG 
TGAACCTACGAGTACACCGA 7901 to 7920 
TTAACCTI-ITAAGTTAAA- 8316 to 8345 
GATTAAGAGAAC 
GGGGAAGC- 
GAGGTTGACCTG 
CTAGGGTAGAATCC- 
GAGTATGTTG 
CGATCAOGCAGGCGC- 
l3G50 to 13ci31 
13928 t0 13905 
14873 to 14850 
CAAGGAGTG 
HI6514 GTGGGCTATTTAGGCTT- 16540 to 16514 
TATGACCCTG 
Primers L7293 and L7901 were used to amplify the light strand 
whereas primers Hl3631, H13905, H1485O and HlG514 were used ror 
the amplification of the heavy strand of mtDNA. Primers L7901 and 
La316 were used for DNA sequencing. Nuclcotide numbering of 
mtDNA is according to Anderson et al. [l6]. 
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Fig. 1. Detection ol’ multiple mtDNA deletions in a single individual. DNA was trmplilied by PCR from heart (H). brain (U) and skeletal muscle 
(Yvl), and the products visualised using cthidium bromide following separation by agnrosc gel electrophorcsis. The rollowing primer combinations 
were used: lanes b, c and d: L7901 and H13631; lanes e. f and 6: L7901 and H 13905; lanes h, i and j: L7POl and H 14850; lanes k, I and m: L7901 
and HlG514: lanes n, o and p: L7293 and H13631. Lanea contains R DNA digested with EcoRI and Hi/rdllI; sizes of some fragments (in kb) are 
shown at the IcIt. For each group of lanes, corresponding to n particular primer combination, arc indicated the positions and code numbers of 
PCR products containing deletions (Table Ii). 
found to be different from deletion 9-1 that was initially 
assumed to be the same deletion in the brain. Deletions 
9-l and 9-2 represent deletions of 8041 bp and 8044 bp 
in brain and muscle, respectively (Table III). The same 
5 bp direct repeat (CCCAT) was found in the vicinity 
of the deletion breakpoint in each case. However, one 
copy of the repeat was deleted in the brain, but both 
copies were partially deleted in the skeletal muscle. 
4. DISCUSSION 
As predicted on the basis of the general theory that 
mutations in the mtDNA accumulate with age, multiple 
mtDNA deletions were found in an elderly human indi- 
vidual with no known mitochondrial disease. Using 
PCR, at least 10 mtDNA deletions have been detected 
in a B-year-old female subject. Tissue-specific deletions 
Tab!e II 
Detection of muItiplc mtDNA deletions in kt G9-yeitr-old female subject 
Primer 
pair 
17901 
Hl3G31 
Distance between Expected size Amplified fragments (bp) Predicted Deletion 
IWO primers (bp) after 4977 bp deletion code 
deletion (bp) Weart Brain Muscle size (kb) number 
5750 773 0.77 0.77 Ct.77 4,98 I 
I.7901 6028 1051 1 .os 1 .u5 1 .QS 4.98 2 
H139OS 0,20 5.83 3 
L7POi 6973 1996 0.64 6.33 4 
H14850 
L7POI 8640 3G63 I .20 1.20 1.20 7.44 5 
H16514 I.01 7.63 6 
0.90 7.14 7 
0.78 7.86 8 
0.60 0.60 0.60 8.04 9 
-.--..--..--.-..-......-..--.................-....................-.........~.*~..,..“.....-..”.....--~.-................~.-.............-.......-.......~.-...~............-.~..__ 
L7293 6358 1381 1.35 1.38 1.38 4.98 10 
H13631 0.60 5.76 II 
The table lists bands visible amongs PCR products in Fig. 1. Other hint bands could be seen in various lanes but are not listed here. 
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were also demonstrated, suggesting that the accumula- 
tion of deletions in individual tissues may occur inde- 
pendently, emphasising the stochastic nature of the 
processes leading to mtDNA deletions. We have not 
quantitated the abundance of each deletion as a propor- 
tion of normal mtDNA. Cortopassi and Arnheim [3] 
estimated the 4977 bp deletion to account for about 
0.1% of mtDNA in the samples they studied. It is 
further not known if these age-related eletions are dis- 
tributed evenly between cells era tissue, or concentrated 
in a limited fraction of  cells. 
One feature of the results presented here is that not 
all deletions present between a given pair of primers are 
represented in the final product. In general, the further 
apart the primers are on mtDNA, the larger are the 
deletions observed (Table I1). It is a well established 
feature of PCR that when a population of differentially 
sized templates are present, smaller products tend to be 
amplified preferentially. The largest amplified product 
in Table II is 1.38 kb, although larger products were 
predicted on the basis of deletions that were already 
identified using more closely apposed primers. One 
might generalise that each pair of primers would pref- 
erentially amplify mtDNA carrying the longest avail- 
able deletions between the priming sims. This appar- 
ently holds in some instances, for example 1.7901 + 
H16514 combination in Table II. Whilst for the primer 
combination L 7901 + H14850 a 0.64 kb product is 
observed in muscle (Table II), no clear bands were ob- 
served in heart or brain, although there were faint ba~ds 
Table 111 
Nucleotide sequences of lhe deletion breakpoint regions 
Deletion Tissue Deletion Sequence 
number analyzed size (bp) 
1 M u~ele 4977 
2 Brain 4977 
3 Muscle 5827 
4 Muscle 6335 
5 Heart 7436 
6 Muscle 7635 
7 Muscle 7737 
8 Muscle 7856 
9-1 Brain 8041 
9-2 Muscle 8044 
10 Heart 4977 
! 1 Muscle 5756 
8470 13447 
ACTACCACCTACCTCCCTCACCA (A A GCC . . . . . . . . . .  CTTCA CCTCCCTCA CCA ) "I-rGG CAGCCT 
8470 13447 
ACTACCACCTACCTCCCTCACCA (A A GCC . . . . . . . . . .  CTTCA A CCTCCCTCA CCA ) "l~l'G G CAGCCT 
7954 13781 
CCTACATACTTCCCCC (A T'FA T . . . . . . . . . .  A A CA A TCCCCC)  TCTACCTAAA 
8470 14805 
ACTACCACCTACCTCCC (TCA CC . . . . . . . . . .  CA TCGA CCTCCC)  CACCCCATCC 
8367 16073 
CCAAATATCTCATCAACAACCG (A CTA A . . . . . . . . . .  TCA CCCA TCA A CA A CCG) CTATGTATTT 
8433 16068 
CTATTCCTCATCACCCA (A CTAA . . . . . . . . . .  TTGA CTCA CCCA ) TCAACAACCG 
7986 15723 
GGCGACCTGCGACTCCT (TGA CU . . . . . . . . . .  TTA TTGA CTCC'F) AGCCGCAGAC 
8027 16071 
CAGC'rTCATGCCCATCG (TCCT . . . . . . . . . .  ACTC') ACCCATCAACAACCGCT 
8030 16071 
GA'I ' rGAAGCCCCCAT (TCGTA . . . . . . . . . .  A CTCA CCCA 7") CAACAACCGC 
8030 16071 
GATTGAAGCCC (CCA TTCGTA . . . . . . . . . .  A CTCA CCCA ) TCAACAACCGC 
8470 13447 
ACTACCACCTACCTCCCTCACCA (AA GCC . . . . . . . . . .  CTTCd A CCT'CCCT'Cd CCA) TTGGCAGCCT 
7769 13525 
TCAGG/X.AATAGAAACCG (TCTGA . . . . . . . . . .  TCA TCC3A A A CCO") CAAACATA 
Direct repeat sequences are underlined and the numbers above each sequence indicate he position of the first nuclcotide of each repeat. The 
numbering of nu¢leotides is at, cording to that of Anderson at el. [16]. The brcakpoints arc indicated byparenthe~s and the nudeotides shown inside 
the parentheses (indicated by italics) were deleted. 
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iij&i CO& r&$‘:scfi. 7 further XX pmduc:s amplified in 
place of the 4977 bp deletion known to be present in 
these tissues. 
Among the various deletions detected in the subject 
of this study, the 4977 bp deletion and the 7436 bp 
deletion have been previously shown to occur in an 
age-related manner. In our previous tudy [2],‘the 4977 
bp deletion was detected in tissues of 8 adults 40 years 
and older, tested after 30 cycles of PCR amplification, 
whereas the same deletion could be detected in tissues 
of two infants up to three months only after 60 cycles 
of amplification. Cortopassi and Arnheim [3] (studying 
brain and heart) showed that this deletion was found in 
adults (21 years and above) but not in fetal samples. 
Yen et al. [4] (focusing on liver) showed the increasing 
incidence of this deletion in successive decades of life. 
Hattori et al. [ 131 have demonstrated the ag -associated 
occurrence of the 743G bp deletion in cardiomyocytes, 
the incidence of this deletion increased steadily through 
successive life decades. This particular deletion had 
been previously detected in the cardiomyocytes of car- 
diomyopathy patients by Ozawa et al. [12], who 
proposed a close relationship between this deletion and 
the disease tiology. In the present study, this deletion 
(deletion 5 in Table 111) was detected and its breakpoint 
sequenced in the heart. On the basis of gel mobility of 
the PCR product of 1.20 kb (Fig. I and Table II) and 
sequencing data (not shown), we suggest hat the same 
deletion is present in the brain and skeletal muscle of 
this non-cardiomyopathy patient. The occurrence of 
this deletion may thus not be limited to the heart, which 
therefore questions a specific relationship between this 
deletion and cardiomyopathy. 
It has been proposed that mitochondrial diseases are 
the consequences of an accelerated form of a natural 
ageing process involving mtDNA damage [2,17]. Multi- 
ple mtDNA deletions have been described in patients 
with mitochondrial diseases [S-l l] and cardiomyopathy 
[12]. Probably, the susceptibility to accumulation of 
deletions varies in individuals. In some cases, notably 
mitochondrial ,disease patients, the accumulation of 
mtDNA deletions may occur at a fast rate, The 
threshold to express mitochondrial diseases would thus 
be reached early in life. On the other hand, most healthy 
people would accumulate such deletions lowly during 
the ageing process. These may contribute, along with 
other mutagenic hanges in mtDNA such as free radi- 
cal-induced amage [ 18,191, to the general loss of mito- 
chondrial bioenergetic output that is part of the ageing 
process [1,20]. 
The accumulation of deletions on the mitochondrial 
genome during ageing may be a general biological phe- 
nomenon in mammals. Piko et al. [21] have reported the 
accumulation with age of mtDNA deletions in labo- 
ratory mice. Moreover, we have observed in laboratory 
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TC:S ?n n?e-r:!z:cd %r?NA deletion of 4834 bp between 
a p&i. Gr” ;s bi/ &&_& ii-Lc_’ ~~ ::: .,.. bAj%S lying within ii 
sector bounded by the heavy and li$t strat?d oriqins of 
replication (A, Boubolas, R.J. Maxwell, A.W. Linnane 
and P. Nagley, unpublished). 
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